Apple and the Stanford University jointly launched a new study on atrial fibrillation, the Apple Heart Study, the first use of consumer-class wearable equipment Is the core of this study.
The study was announced by Apple at the launch of Apple Watch Series 3. Apple pointed out that the study will be carried out in cooperation with the US Food and Drug Administration. According to Apple, Apple Watch is the world's most frequently used heart rate monitor, this device's huge user base for Apple and Stanford University provides a lot of potential research data.
Atrial fibrillation is a change in the normal rhythm of the heart characterized by irregular beating, which is usually difficult to detect because it is no obvious external symptoms, but the risk of thrombosis and stroke is present in the disease.
In North America and Europe, 2% to 3% of people are affected by this disease. Of the 60- to 70-year-olds, 4% have this disease, which is 14% of people over 80 years of age. In 2015, atrial fibrillation resulted in 193,000 deaths.
Apple at the press conference did not disclose Apple Heart Study this study specific release date. It is understood that the first phase of the study results will be released later in 2017 on the App Store.
In addition to detecting heart problems, blood glucose monitoring is the next health issue that Apple is trying to address. Earlier this year, a report said Apple already had a biomedical engineering team dedicated to developing noninvasive blood glucose level monitoring sensors and is developing a continuous monitoring solution that does not require skin sensors.